Radiation Dermatitis following Radioembolization for Hepatocellular Carcinoma: A Case for Prophylactic Embolization of a Patent Falciform Artery

Journal of Vascular and Interventional Radiology

Volumn 20, Issue 6, 2009, Pages 833-836

  Leong, Quor M ^a,b   Lai, Hee K ^a   Lo, Richard G H ^a   Teo, Terence K B ^a   Goh, Anthony ^a   Chow, Pierce K H ^a,c  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b TAN TOCK SENG HOSPITAL   (Singapore)

^c Singapore Graduate Medical School   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

TECHNETIUM 99M; YTTRIUM 90;

ADULT; ARTICLE; BRACHYTHERAPY; CASE REPORT; CLINICAL FEATURE; HUMAN; LIVER CELL CARCINOMA; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DERMATITIS;

CARCINOMA, HEPATOCELLULAR; EMBOLIZATION, THERAPEUTIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RADIODERMATITIS;

EID: 67349194644     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2009.03.011     Document Type: Article

References (15)

1. Yan Z.P., Lin G., Zhao H.Y., and Dong Y.H. An experimental study and clinical pilot trials on yttrium-90 glass microspheres through the hepatic artery for treatment of primary liver cancer. Cancer 72 (1993) 3210-3215
2. Shepherd F.A., Rotstein L.E., Houle S., Yip T.C., Paul K., and Sniderman K.W. A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma. Cancer 70 (1992) 2250-2254
3. Andrews J.C., Walker S.C., Ackermann R.J., Cotton L.A., Ensminger W.D., and Shapiro B. Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. J Nucl Med 35 (1994) 1637-1644
4. Lau W.Y., Ho S., Leung T.W., et al. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intra-arterial infusion of 90yttrium microspheres. Int J Radiat Oncol Biol Phys 40 (1998) 583-592
5. Khodjibekova M., Szyszko T., Khan S., Nijran K., Tait P., and Al-Nahhas A. Selective internal radiation therapy with Yttrium-90 for unresectable liver tumors. Rev Recent Clin Trials 2 (2007) 212-216
6. Mallach S., Ramp U., Erhardt A., Schmitt M., and Haussinger D. An uncommon cause of gastro-duodenal ulceration. World J Gastroenterol 14 (2008) 2593-2595
7. Cheng J.C., Wu J.K., Huang C.M., et al. Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description. Radiother Oncol 63 (2002) 41-45
8. Leung T.W., Lau W.Y., Ho S.K., et al. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys 33 (1995) 919-924
9. Goh A.S., Chung A.Y., Lo R.H., et al. A novel approach to brachytherapy in hepatocellular carcinoma using a phosphorous32 (32P) brachytherapy delivery device-a first-in-man study. Int J Radiat Oncol Biol Phys 67 (2007) 786-792
10. Ueno K., Miyazono N., Inoue H., Miyake S., Nishida H., and Nakajo M. Embolization of the hepatic falciform artery to prevent supraumbilical skin rash during transcatheter arterial chemoembolization for hepatocellular carcinoma. Cardiovasc Intervent Radiol 18 (1995) 183-185
11. Chernyak I., Bester L., Freund J., and Richardson M. Anterior abdominal wall uptake in intrahepatic arterial brachytherapy with yttrium-90 sir spheres for hepatic malignancy. Clin Nucl Med 33 (2008) 677-680
12. Liu D.M., Salem R., Bui J.T., et al. Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 16 (2005) 911-935
13. Song S.Y., Chung J.W., Lim H.G., and Park J.H. Nonhepatic arteries originating from the hepatic arteries: angiographic analysis in 250 patients. J Vasc Interv Radiol 17 (2006) 461-469
14. Gibo M., Hasuo K., Inoue A., Miura N., and Murata S. Hepatic falciform artery: angiographic observations and significance. Abdom Imaging 26 (2001) 515-519
15. Michels N.A. Collateral arterial pathways to the liver after ligation of the hepatic artery and removal of the celiac axis. Cancer 6 (1953) 708-724